This page is a guide to ARKG, the ARK Genomic Revolution Multi-Sector ETF offered by ARK.
Last Price
$15.02
-4.73%
How is ARKG Categorized as an ETF?
All ETFs
1,754 funds
Asset Class
985 ETFs
Category
273 ETFs
Sub-Category
9 ETFs
How Does ARKG Compare to Its Category Competitors?
The percentile shown for each metric indicates how ARKG compares to other ETFs in the Sector Stock category. Wondering how percentiles work? Short version: 99th percentile is good, 0th is bad.
Assets and Yield
Assets (Millions)
$6.83
3rd Percentile
Dividend Yield
N/A
N/A
Returns
YTD Return
-18.89%
4th Percentile
5 Year Return
N/A
N/A
Portfolio
Number of Holdings
42
45th Percentile
% Assets in Top 10
50.94%
43rd Percentile
Expenses
Expense Ratio
0.95%
5th Percentile
Fund Turnover
N/A
N/A
ARKG vs. Other Sector Stock ETFs: All the Data You Could Possibly Want
The table below shows additional financial metrics for ARKG as well as all other ETFs in the Sector Stock category. To compare ARKG to its broader asset class peer group, visit the Stock page. To compare ARKG to its narrower sub-category peer group, visit the Biotech ETFs page.
Click on the tabs (Expenses, Returns, Yield, Holdings) to view additional data for ARKG and all ETFs in the Sector Stock category.
| Ticker | ETF | Assets ($M) | Inception Date | Issuer |
|---|---|---|---|---|
| Category Average | N/A | $821.16 | N/A | N/A |
| Ticker | ETF | Expense Ratio | Fund Turnover |
|---|---|---|---|
| Category Average | N/A | 0.62% | 33.14% |
| Ticker | ETF | YTD | 1-Month | 3-Month | 6-Month | 1-Year | 3-Year | 5-Year | 10-Year |
|---|---|---|---|---|---|---|---|---|---|
| Category Average | N/A | -7.91% | -7.58% | -11.49% | -15.36% | -13.96% | 1.53% | 2.85% | 5.10% |
| Ticker | ETF | 12 Month Yield | 30 Day SEC Yield | Dividend Frequency | Capital Gains Frequency |
|---|---|---|---|---|---|
| Category Average | N/A | 3.03% | 2.29% | N/A | N/A |
| Ticker | ETF | Number of Holdings | Number of Long Holdings | Number of Short Holdings | % Assets in Top 10 |
|---|---|---|---|---|---|
| Category Average | N/A | 84 | 84 | 2 | 47.79% |
ARKG Portfolio
| Asset Class | Weight |
|---|---|
| US Stock Weighting | 87.59% |
| Non US Stock Weighting | 12.19% |
| Other Weighting | 0.22% |
| Top Holdings | Weight |
|---|---|
| Illumina Inc | 8.36% |
| Foundation Medicine Inc | 6.16% |
| Medidata Solutions Inc | 6.05% |
| Cerus Corp | 4.99% |
| Monsanto Co | 4.91% |
| Cepheid | 4.54% |
| Compugen Ltd | 4.36% |
| Alnylam Pharmaceuticals Inc | 4.32% |
| Regeneron Pharmaceuticals Inc | 3.63% |
| AthenaHealth Inc | 3.61% |
Other ARKG Metrics
Management
- Issuer
- ARK
- Inception Date
- 10/30/2014
- Management Style
- Active
- Benchmark
- Not Benchmarked
Dividend Data
- Dividend Frequency
- Annually
- Capital Gains Frequency
- N/A
- Annual Dividend
- N/A
Pricing Data
- Day Range
- $15.00 / $15.30
- Bid/Ask
- $15.21 / $15.78
- 52 Week Low/High
- $15.00 / $24.94
Other Information
- Leveraged Fund
- No
